Heart

2

Review clinical trials related to Heart. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

Participants needed: 42
Trial details
Phase: Phase 1Age: 50+Biological sex: AllType: InterventionalSponsor: Vasa TherapeuticsUpdated: Apr 9, 2026Locations: 21
Eligibility criteria

Males or females ≥ 50 years of age at the time of signing the informed consent. [+10]

Female trial participant who is pregnant or breastfeeding. [+11]

Status: Recruiting

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

TRICS-IV is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in moderate to high risk patients who are 65 years of age or younger undergoing cardiac surgery on cardiopulmonary bypass, using a superiority trial design.

Participants needed: 1,440
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Unity Health TorontoUpdated: Nov 21, 2024Locations: 54
Eligibility criteria

≥18 and ≤65 years of age [+3]

Patients who refuse participation [+4]